ArticleLancet (London, England)2020
COVID-19 vaccines: early success and remaining challenges.
Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Article
- Targeting mucin hypersecretion in COVID-19 therapy.Future medicinal chemistry · 2022Article
- Dynamical analysis of the infection status in diverse communities due to COVID-19 using a modified SIR model.Nonlinear dynamics · 2022Article
- An outlook on antigen-specific adoptive immunotherapy for viral infections with a focus on COVID-19.Cellular immunology · 2021Review
- Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLInternational journal of biological macromolecules · 2021Article
- Prediction of individual COVID-19 diagnosis using baseline demographics and lab data.Scientific reports · 2021Article
- International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.The Milbank quarterly · 2021Article
- Article
- COVID-19 vaccine: Call for employees in international transportation industries and international travelers as the first priority in global distribution.Open medicine (Warsaw, Poland) · 2021Article
- COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD.ERJ open research · 2021Article
- Missed Opportunities of Flu Vaccination in Italian Target Categories: Insights from the Online EPICOVID 19 Survey.Vaccines · 2020Article
- Isolating SARS-CoV-2 Strains From Countries in the Same Meridian: Genome Evolutionary Analysis.JMIR bioinformatics and biotechnologyArticle
- A comprehensive review of various categories of face masks resistant to Covid-19.Clinical epidemiology and global healthReview
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.